By joining, you will: Receive updates as scheduling becomes available Be notified first when appointments open Learn more about eligibility, insurance, and next steps Your information is kept private and used only to communicate about GLP-1 services
doi:10.1016/j.molmet.2018.05.014 52
June 12th, 2025: EMA Links Semaglutide to Rare Vision Disorder The European Medicines Agency (EMA) has formally acknowledged a potential link between semaglutide, the key ingredient in Ozempic, Wegovy, and Rybelsus, and a rare but serious eye condition known as non-arteritic anterior ischemic optic neuropathy (NAION)
The human data, while limited, is directionally aligned with decades of preclinical work across multiple species
Heres how: Improving Metabolic Health : High blood sugar levels and obesity are linked to lower testosterone levels and poor sperm quality in men